Keystone Clinical Studies ( Site 1031) — Plymouth Meeting, Pennsylvania

Keystone Clinical Studies ( Site 1031) is a clinical research site located in Plymouth Meeting, Pennsylvania, United States 19462.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Keystone Clinical Studies ( Site 1031) has participated in 1 clinical trials.

Therapeutic areas: Treatment Resistant Depression.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Keystone Clinical Studies ( Site 1031)?

Keystone Clinical Studies ( Site 1031) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Keystone Clinical Studies ( Site 1031) conducted?

Keystone Clinical Studies ( Site 1031) has 1 clinical trials on record. Their work covers Treatment Resistant Depression.

Is Keystone Clinical Studies ( Site 1031) accredited by Crixeo Health?

Keystone Clinical Studies ( Site 1031) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Keystone Clinical Studies ( Site 1031)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.